Education
About Us
Working with TipRanks
Follow Us
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
Earnings Data
Report Date
Mar 03, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.15Last Year’s EPS
-1.01Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlights Aclaris' strong financial position and promising advancement of ATI-2138, despite some challenges in cash reserves and competitive landscape considerations. The company is making strategic moves in its drug development with a focus on efficiency and differentiation.Company Guidance
Strong Financial Position
Aclaris ended the first quarter with $161 million in cash, cash equivalents, and marketable securities, with no outstanding debt. This positions the company well financially for upcoming initiatives.
Advancement of ATI-2138
Decision to move ATI-2138 forward in a proof-of-concept study for moderate to severe atopic dermatitis, showing promising preclinical and Phase I results.
Cost Containment Success
Cost containment initiatives are on track, with significant reductions in cash expenditures expected for the remainder of the year.
Potential Best-in-Class Treatment
ATI-2138 shows potential as a best-in-class dual inhibitor of ITK and JAK3, designed to treat autoimmune diseases with a favorable safety profile.
ACRS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ACRS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $2.36 | $2.26 | -4.24% |
Aug 06, 2025 | $1.55 | $1.55 | 0.00% |
May 08, 2025 | $1.25 | $1.31 | +4.80% |
Feb 27, 2025 | $2.10 | $1.95 | -7.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Aclaris Therapeutics (ACRS) report earnings?
Aclaris Therapeutics (ACRS) is schdueled to report earning on Mar 03, 2026, Before Open (Confirmed).
What is Aclaris Therapeutics (ACRS) earnings time?
Aclaris Therapeutics (ACRS) earnings time is at Mar 03, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ACRS EPS forecast?
ACRS EPS forecast for the fiscal quarter 2025 (Q4) is -0.15.